TIMP2 and breast carcinoma: For this reason, we first analyzed the mRNA expression levels of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, TIMP-3 and RECK, in the same panel of five human breast cancer cell lines, but now maintained in culture until achieving 80-90% confluence.